Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06754280 · ClinicalTrials.gov registry record · NA
An Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease
A NA study of Chronic Kidney Disease (CKD), sponsored by University of Illinois at Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06754280: Recruiting NA study of Chronic Kidney Disease (CKD), sponsored by University of Illinois at Chicago.
NCT06754280 is a NA study of Chronic Kidney Disease (CKD) that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 40 participants, below the 1,413-participant average among 14 other Chronic Kidney Disease (CKD) trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06754280, a NA study of Chronic Kidney Disease (CKD), is actively recruiting participants, sponsored by University of Illinois at Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
RESET-CKD is evaluating an intervention to support Black adults with chronic kidney disease (CKD) to reduce their sedentary (e.g., sitting) time. Half of the participants will be randomized to the intervention, where the goal is to support individuals to reduce their sitting time, and the other half will be randomized to an attention control condition that provides CKD-related education not related to sedentary behavior. All participants will be followed for 12 weeks.
Primary Outcome
Change in activPAL-measured sedentary time
Conditions Studied
Interventions
- OTHER Attention Control
- BEHAVIORAL RESET-CKD
Study Locations (1)
Illinois
- UI Health/University of Illinois Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-03-13 |
| Est. Completion | 2027-05 |
| Phase | NA |
What NCT06754280 shows while recruiting
NCT06754280 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,413-participant average among 14 other Chronic Kidney Disease (CKD) trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Chronic Kidney Disease (CKD) appearing as the primary indexed condition, and to 2 interventions - of which Attention Control is the first listed.
NCT06754280 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06754280 about?
NCT06754280 is a clinical study titled "An Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease". RESET-CKD is evaluating an intervention to support Black adults with chronic kidney disease (CKD) to reduce their sedentary (e.g., sitting) time. Half of the participants will be randomized to the intervention, where the goal is to support individuals to reduce their sitting time, and the other half...
What is the current status of trial NCT06754280?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-03-13. Estimated completion is 2027-05.
What conditions does trial NCT06754280 study?
This clinical trial studies the following conditions: Chronic Kidney Disease (CKD).
What interventions are being tested in trial NCT06754280?
The interventions under investigation include: Attention Control (OTHER), RESET-CKD (BEHAVIORAL).
Who is sponsoring clinical trial NCT06754280?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06754280 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Disease (CKD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06754280's enrollment target sits among peer trials
40 14th of 14 higher than 1 of 14 other Chronic Kidney Disease (CKD) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Kidney Disease (CKD) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exercise and Monitoring With Post-Hospitalization Muscle Atrophy to Sustain Intrinsic Capacity and Strength
RECRUITING · NA
-
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
RECRUITING · NA
-
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
RECRUITING · NA
-
Virtual Nephrologist
COMPLETED · NA
-
An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant
RECRUITING
-
A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA)
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI